Karmanos Cancer Institute — Detroit, Michigan

Karmanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute has participated in 472 clinical trials with 153 currently active.

Therapeutic areas: Neoplasms, Carcinoma, Non Small Cell Lung, Breast Neoplasms.

Sponsors: Pfizer, Hoffmann-La Roche, Afimmune.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute?

Karmanos Cancer Institute has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute conducted?

Karmanos Cancer Institute has 472 clinical trials on record, with 153 currently active. Their work covers Neoplasms, Carcinoma, Non Small Cell Lung, Breast Neoplasms.

Is Karmanos Cancer Institute accredited by Crixeo Health?

Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.